MALLINCKRODT PLC

In News

Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics - PR Newswire

PR Newswire - Nov 10, 2025

Mallinckrodt Shareholder Action Reminder - TMX Newsfile

TMX Newsfile - Aug 05, 2026

Mallinckrodt's Ch. 11 Blocks Antitrust Payouts, Judge Rules - Law360

Law360 - Feb 24, 2026

Attorney General Josh Stein Announces $233 Million Multistate Medicaid Settlement with Mallinckrodt - NCDOJ (.gov)

NCDOJ (.gov) - Jun 17, 2022

Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables - PR Newswire

PR Newswire - Nov 10, 2025

Drugmaker Mallinckrodt emerges from bankruptcy - Reuters

Reuters - Nov 14, 2023

Mallinckrodt completes the spin-off of Par Health - Arthur Cox LLP

Arthur Cox LLP - Nov 11, 2025

Mallinckrodt and Endo Announce Merger, Possible Spin - akingump.com

akingump.com - Mar 26, 2025

Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting - PR Newswire

PR Newswire - Oct 31, 2025

Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer - PR Newswire

PR Newswire - Sep 22, 2025

Mallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance - PR Newswire

PR Newswire - Aug 06, 2025

Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader - PR Newswire

PR Newswire - Aug 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment